Fasoracetam

Fasoracetam is a synthetic racetam nootropic that enhances cognitive function by modulating AMPA receptors and metabotropic glutamate receptors (mGluR). It influences GABA and glutamate neurotransmitter systems to improve memory, learning, and attention while potentially reducing ADHD symptoms.

Origin & History

Fasoracetam is a synthetic compound belonging to the racetam family, originally developed in Japan as a treatment for vascular dementia. It is produced through a series of chemical reactions that modify the pyrrolidone nucleus, characteristic of racetams.

Historical & Cultural Context

Initially developed in the 1990s for dementia treatment, fasoracetam has gained popularity in the nootropic community for its cognitive-enhancing properties.

Health Benefits

- Enhances cognitive function by modulating neurotransmitter systems, leading to improved memory and learning. This results in quicker information processing and recall. - Reduces symptoms of ADHD by influencing glutamate and GABA pathways, which are critical for attention and focus. This can lead to improved concentration and reduced hyperactivity. - Supports mood stabilization by modulating serotonin and dopamine receptors, which are involved in emotional regulation. This results in a more balanced emotional state and reduced anxiety. - Enhances stress resilience by modulating the stress hormone cortisol, leading to improved mood and reduced anxiety. This helps maintain mental clarity under pressure. - Supports neuroprotection by reducing oxidative stress and inflammation in the brain. This protective effect may contribute to long-term brain health. - Increases motivation and drive by influencing dopamine pathways, which are linked to reward and pleasure. This can lead to greater productivity and goal achievement. - Enhances learning ability by promoting neurogenesis, the formation of new neurons. This process is vital for adapting to new information and environments.

How It Works

Fasoracetam acts as a positive allosteric modulator of AMPA receptors and metabotropic glutamate receptors, particularly mGluR1 and mGluR5. It enhances glutamatergic transmission while modulating GABAergic activity through upregulation of GABA-B receptors. The compound also influences the cholinergic system by increasing acetylcholine release in the hippocampus.

Scientific Research

Fasoracetam has been studied in animal models and small human trials, showing promise in cognitive enhancement and ADHD symptom reduction. Further large-scale RCTs are needed to confirm these effects.

Clinical Summary

Human clinical trials on fasoracetam remain limited, with most evidence from small-scale studies on ADHD populations. One phase II trial examined 30 adolescents with ADHD and glutamatergic gene mutations, showing modest improvements in attention scores. Animal studies demonstrate enhanced learning and memory formation, but human cognitive enhancement data is primarily anecdotal. Larger randomized controlled trials are needed to establish definitive therapeutic benefits.

Nutritional Profile

- Synthetic compound with no caloric or macronutrient content.
- Primarily acts on neurotransmitter systems rather than providing nutritional value.
- Interacts with glutamate, GABA, and acetylcholine pathways.

Preparation & Dosage

Typical dosage ranges from 10-30 mg per day, divided into two doses. Consult a healthcare provider before use.

Synergy & Pairings

Alpha-GPC, CDP-Choline, Huperzine A

Safety & Interactions

Common side effects include mild headache, nausea, and fatigue at doses above 20mg twice daily. Fasoracetam may interact with GABA receptor medications and could potentially enhance effects of anticonvulsants. No major drug interactions have been reported, but caution is advised with other nootropics targeting glutamate systems. Safety during pregnancy and breastfeeding has not been established, and use should be avoided in these populations.